%0 Journal Article
%T Dense tumor-infiltrating lymphocytes (TILs) in liver metastasis from colorectal cancer are related to improved overall survival.
%A Vaz da Silva DG
%A de Ribeiro HSC
%A Dos Santos GO
%A Lindote MVN
%A Torres SM
%A Diniz AL
%A de Godoy AL
%A de Farias IC
%A Felismino TC
%A da Costa Junior WL
%A Coimbra FJF
%J J Surg Oncol
%V 0
%N 0
%D 2024 Jul 1
%M 38946284
%F 2.885
%R 10.1002/jso.27759
%X <B>OBJECTIVE: </B>Tumor-infiltrating lymphocytes (TILs) represent a host-tumor interaction, frequently signifying an augmented immunological response. Nonetheless, implications with survival outcomes in patients with colorectal carcinoma liver metastasis (CRLM) warrant rigorous validation. The objective was to demonstrate the association between TILs and survival in patients with CRLM.<BR><B>METHODS: </B>In a retrospective evaluation conducted in a single institution, we assessed all patients who underwent hepatectomy due to CRLM between 2014 and 2018. Comprehensive medical documentation reviews were executed. TILs were assessed by a liver pathologist, blinded to the clinical information, in all surgical slides.<BR><B>RESULTS: </B>This retrospective cohort included 112 patients. Median overall survival (OS) was 58 months and disease-free survival (DFS) was 12 months for the entire cohort. Comparison between groups showed a median OS of 81 months in the dense TILs group and 40 months in the weak/absent group (p = 0.001), and DFS was 14 months versus 9 months (p = 0.041). Multivariable analysis showed that TILs were an independent predictor of OS (HR 1.95; p = 0.031).<BR><B>CONCLUSIONS: </B>Dense TILs are a pivotal prognostic indicator, correlating with enhanced OS. Including TILs information in histopathological evaluations should refine the clinical decision-making process for this group of patients.